DUREPLACE Canadian Trademark Information

On Friday, January 10, 2003, a canadian trademark registration was filed for DUREPLACE by TRANSKARYOTIC THERAPIES, INC. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1164871. The current status of this trademark filing is Interruption of proceeding. The DUREPLACE trademark is filed in the description of Pharmaceuticals and biologics for use in the treatment of genetic disorders, endocrine disorders, short stature, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders and enzyme deficiency diseases, namely: pharmaceuticals and biologics for iduronate-2-sulfatase (I2S) deficiency for the treatment of Hunter's syndrome, also referred to as MPS II; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of Hunter's syndrome also referred to as MPS II, and for implantation into human patients.. , Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services, namely: providing at home infusion services and patient assistance related to infusion therapy; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics. , Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services, namely: providing at home infusion services and patient assistance related to infusion therapy; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics. , Pharmaceuticals and biologics for use in the treatment of genetic disorders, endocrine disorders, short stature, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders and enzyme deficiency diseases, namely: pharmaceuticals and biologics for iduronate-2-sulfatase (I2S) deficiency for the treatment of Hunter's syndrome, also referred to as MPS II; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of Hunter's syndrome also referred to as MPS II, and for implantation into human patients.. , Pharmaceuticals and biologics for use in the treatment of genetic disorders, endocrine disorders, short stature, metabolic disorders, disorders of the central nervous system, gastrointestinal disorders, cardiovascular disorders and enzyme deficiency diseases, namely: pharmaceuticals and biologics for iduronate-2-sulfatase (I2S) deficiency for the treatment of Hunter's syndrome, also referred to as MPS II; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of Hunter's syndrome also referred to as MPS II, and for implantation into human patients.. , Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services, namely: providing at home infusion services and patient assistance related to infusion therapy; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologics. .